Cargando…
Current Control and Future Risk in Asthma Management
Despite international and national guidelines, poor asthma control remains an issue. Asthma exacerbations are costly to both the individual, and the healthcare provider. Improvements in our understanding of the therapeutic benefit of asthma therapies suggest that, in general, while long-acting bronc...
Autores principales: | Sims, Erika J, Price, David, Haughney, John, Ryan, Dermot, Thomas, Mike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178819/ https://www.ncbi.nlm.nih.gov/pubmed/21966601 http://dx.doi.org/10.4168/aair.2011.3.4.217 |
Ejemplares similares
-
Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD
por: Price, David, et al.
Publicado: (2011) -
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study
por: Kemp, Linda, et al.
Publicado: (2010) -
Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm
por: Blakey, John D, et al.
Publicado: (2013) -
Implications of Pharmacogenomics in the Current and Future Treatment of Asthma
por: Morrow, Thomas J.
Publicado: (2007) -
A multinational observational study identifying primary care patients at risk of overestimation of asthma control
por: Kritikos, Vicky, et al.
Publicado: (2019)